About the Exhibition
The China-Africa Economic and Trade Expo was announced by President Xi Jinping at the Beijing Summit of the Forum on China-Africa Cooperation in 2018. It is China's first national-level economic and trade cooperation platform with Africa. Co-sponsored by Ministry of Education and Hunan Provincial People's Government. With the strong support and active participation of all parties, the China-Africa Economic and Trade Expo has been successfully held twice in 2019 and 2021, attracting a total of 53 African countries, more than 10 international organizations, 31 Chinese local provinces, autonomous regions and municipalities, and 29 China's national ministries and agencies, more than 200 central enterprises and their subsidiaries, thousands of Chinese and African enterprises, business associations and financial institutions participated in the exhibition; all parties signed a total of 216 cooperation projects or cooperation agreements with a value of 43.02 billion U.S. dollars. With practical and fruitful results, it has become a new platform for the implementation of economic and trade measures of the Forum on China-Africa Cooperation and a new window for local Chinese economic and trade cooperation with Africa.
From June 29th to July 2nd, VACURE is presenting its microfluidic fluorescent immunoassay system at the 3rd China-Africa Expo, booth No. E1-C71.
The theme of this year is "Common Development and Shared Future", which is also one of the most important exchange activities between China and 
African countries in the economic and trade field this year. The expo will set up 8 African countries of honor and 2 theme provinces of Shandong and Hubei. About 30 activities will be held in 5 categories including major events, high-end forums, matchmaking negotiations, special seminars, and supporting activities, including the Counselor Office of the State Council, the State-owned Assets Supervision and Administration Commission of the State The Ministry of Medicine Administration, the China Council for the Promotion of International Trade, the All-China Women's Federation, the All-China Youth Federation and other ministries and agencies will host the activities respectively.
Products
Strip Microfluidic Florescence Immunoassay Diagnostic System
Test cassette
Analyzers
LYOFIA-I
Simple but Smart
· Single channel, 500t/h
· Small but fast
Applicable scenarios :
Emergency department, outpatient department, laboratory department,
clinical department and physical examination center.
LYOFIA8
No need for manual detection
· 8 channels, 96 t/h
· Support continuous sample addition
· Automatic detection
Application scenarios:
Emergency department, laboratory department, clinical department, third- party laboratory, physical examination center, ambulance
LYOFIA100
Fully automatic detection, no need to be on duty
· Fully automatic
· 40 sample positions, 120t/h
Application scenarios :
Emergency department, outpatient clinic, laboratory department, clinical department, physical examination center of general hospitals at all levels
PART II Dish-type Microfluidic Florescence Immunoassay Diagnostic System
DISKFLU
Take it easy
· Single channel, 9 Panel Detection
· Whole blood sample,Self-contained centrifugal
· 15 minutes,get 9 test accurate report
Application scenarios:
Emergency department, third-party laboratory, outpatient clinic, laboratory department, clinical department, physical examination center, ambulance
Pavilion address
Welcome to VACURE, Booth No. E1-C71
29,June - 2,July
ABOUT VACURE
VACURE is a high-tech enterprise focusing on the field of in vitro diagnostic (IVD) point-of-care testing (POCT). The company has gathered many R&D personnel such as the Provincial Thousand Talents Program. Based on core technologies such as microfluidic chip design, time-resolved fluorescent nanomaterials, and inkjet freeze-drying, the company has created POCT immune and molecular products with excellent performance, and realized raw materials, instruments and reagents. The whole chain is self-developed and self-produced, realizing the breakthrough from "Made in China" to "Intelligently Made in China". Adhering to the original intention, we will continue to research and develop a steady stream of accurate and rapid diagnostic products and high-quality services for the medical industry.
